Hits Inc.

tradeKorea tradeshows company E-catalog

tradeKorea tradeshows company E-catalog

Hits Inc.

CEO : Kim Woo Yeon

Adress

124, Teheran-ro, Gangnam-gu, Seoul, Korea

E-mail

ljk@hits.ai

Website

https://hits.ai

Phone No.

82-2-6953-0317

ONE Platform : New Drug Discovery Cloud Platform based on Artificial Intelligence Digitalizing the new drug development process has become an irresistible trend. Most pharmaceutical companies are now focusing on leveraging digital technologies to improve the odds of drug discovery and development success. Nevertheless, existing computer-aided drug discovery(CADD) software on the market does not meet the demand. First of all, conventional CADD softwares (e.g. Amber, Spark, Glide, OpenEye, Chemdraw etc.) are quite expensive, but their accuracy is relatively low compared to its price. Accessibility and user convenience are also inevitably low because conventional softwares are usually on-premise that require installation on certain devices. In addition, complex UX/UI design makes software interpretable only to a few groups of trained CADD researchers. HITS Incorporation (HITS Inc.) has developed a new drug discovery web platform (ONE Platform) based on its own AI technology, which brings the following key advantages to the market. 1. Improved accuracy: ONE platform significantly improves accuracy by applying advanced AI technology. To be more specific, the hit discovery ratio of docking implemented by ONE platform was found to be more than twice as high as that of conventional docking programs.2. User accessibility: ONE platform is developed as a cloud service(SaaS), which dramatically improves accessibility through the web. In addition, ONE platform focuses on implementing intuitive UX/UI from the planning stage. This user-friendly UX/UI of ONE platform lowers the entry barrier for experimental researchers who are especially unfamiliar with digital drug discovery process.3. User convenience: ONE platform offfers all-in-one solution by including various sotwares such as docking, prection of physicochemical properties, molecular dynamics simulations and so on in the single platform interface. Therefore, costumers do not need buy and install different sotwares, but simply subscribe ONE platform having all necessary solutions. In particular, those softwares are automatically updated with new features through the cloud platform, which always provides up-to-date working environments.With its high accuracy, accessibility, and user convenience, One platform will be offered to users at a reasonable price on the market, which will serve as a special competitive edge for HITS Inc.

ONE Platform - AI drug discovery platform

ONE Platform: NewDrug Discovery Cloud Platform based on Artificial Intelligence Digitalizing the new drug development process hasbecome an irresistible trend. Most pharmaceutical companies are now focusing onleveraging digital technologies to improve the odds of drug discovery anddevelopment success. Nevertheless, existing computer-aided drug discovery(CADD)software on th ...View more

Trade Price / Negotiable

MOQ / Min. Order

tradeKorea tradeshows company E-catalog